Hostname: page-component-7bb8b95d7b-w7rtg Total loading time: 0 Render date: 2024-10-05T05:43:32.888Z Has data issue: false hasContentIssue false
  • English
  • Français

Commentary: Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?

Published online by Cambridge University Press:  10 July 2009

Didier Breyer ,
Philippe Herman ,
Annick Brandenburger ,
Godelieve Gheysen ,
Erik Remaut ,
Patrice Soumillion ,
Jan Van Doorsselaere ,
René Custers ,
Katia Pauwels  and
Myriam Sneyers
...Show all authors
Didier Breyer
Affiliation:
Scientific Institute of Public Health, Division of Biosafety and Biotechnology, Rue J. Wytsmanstraat 14, 1050 Brussels, Belgium
Philippe Herman
Affiliation:
Scientific Institute of Public Health, Division of Biosafety and Biotechnology, Rue J. Wytsmanstraat 14, 1050 Brussels, Belgium
Annick Brandenburger
Affiliation:
Université Libre de Bruxelles, IBMM-IRIBHM, Rue des professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium
Godelieve Gheysen
Affiliation:
Ghent University, Department Molecular Biotechnology, Coupure Links 653, 9000 Ghent, Belgium
Erik Remaut
Affiliation:
VIB, Department for Molecular Biomedical Research, Technologiepark 927, 9052 Ghent, Belgium Ghent University, Department of Biomedical Molecular Biology, Technologiepark 927, 9052 Ghent, Belgium
Patrice Soumillion
Affiliation:
Université Catholique de Louvain, Laboratoire d'ingénierie des protéines et des peptides, Institut des Sciences de la Vie, Place Croix du Sud 4-5, bte 3, 1348 Louvain-la-Neuve, Belgium
Jan Van Doorsselaere
Affiliation:
KATHO, Departement verpleegkunde en biotechnologie, HIVB – Campus Roeselare, Wilgenstraat 32, 8800 Roeselare, Belgium
René Custers
Affiliation:
VIB, Rijvisschestraat 120, 9052 Zwijnaarde, Belgium
Katia Pauwels
Affiliation:
Scientific Institute of Public Health, Division of Biosafety and Biotechnology, Rue J. Wytsmanstraat 14, 1050 Brussels, Belgium
Myriam Sneyers
Affiliation:
Scientific Institute of Public Health, Division of Biosafety and Biotechnology, Rue J. Wytsmanstraat 14, 1050 Brussels, Belgium
Dirk Reheul
Affiliation:
Ghent University, Department of Plant Production, Faculty of Bioscience Engineering, Coupure Links 653, 9000 Ghent, Belgium

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the European Union, the definition of a GMO is technology-based. This means that a novel organism will be regulated under the GMO regulatory framework only if it has been developed with the use of defined techniques. This approach is now challenged with the emergence of new techniques. In this paper, we describe regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis to develop novel organisms. We present scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation on GMOs. We conclude that any political decision on this issue should be taken on the basis of a broad reflection at EU level, while avoiding discrepancies at international level.

Keywords

GMOEU regulationgene modificationoligonucleotidenew techniquesmutagenesisrisk assessment
Type
Research Article
Information
Environmental Biosafety Research , Volume 8 , Issue 2 , April 2009 , pp. 57 - 64
Copyright
© ISBR, EDP Sciences, 2009

References

Aarts M, Dekker M, de Vries S, van der Wal A, te Riele H (2006) Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells. Nucleic Acids Res. 34: e147
Agarwal, S, Gamper, HB, Kmiec, EB (2003) Nucleotide replacement at two sites can be directed by modified single-stranded oligonucleotides in vitro and in vivo. Biomol Eng. 20: 7–20 CrossRef
Alexeev, V, Igoucheva, O, Yoon, K (2002) Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Ther. 9: 1667–1675 CrossRef
Andersen, MS, Sorensen, CB, Bolund, L, Jensen, TG (2002) Mechanisms underlying targeted gene correction using chimeric RNA/DNA and single-stranded DNA oligonucleotides. J. Mol. Med. 80: 770–781 CrossRef
BAC (2007) Advice of the Belgian Biosafety Advisory Council on the use of “Targeted Gene Repair” as a strategy to develop novel organisms (ref. WIV-ISP/BAC/2007_SC_529). Belgian Biosafety Advisory Council. http://www.bio-council.be/bac_advices.html (accessed March 3rd, 2009)
BASF (2009) BASF and Cibus achieve development milestone in CLEARFIELD® Production System. http://www.basf.com/group/pressrelease/P-09-119 (accessed March 3rd, 2009)
Beetham, PR, Kipp, PB, Sawycky, XL, Arntzen, CJ, May, GD (1999) A tool for functional plant genomics: chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations. Proc. Natl. Acad. Sci. USA 96: 8774–8778 CrossRef
Bertoni, C, Morris, GE, Rando, TA (2005) Strand bias in oligonucleotide-mediated dystrophin gene editing. Hum. Mol. Genet. 14: 221–233 CrossRef
Campbell, CR, Keown, W, Lowe, L, Kirschling, D, Kucherlapati, R (1989) Homologous recombination involving small single-stranded oligonucleotides in human cells. New Biol. 1: 223–227
Christensen, LA, Finch, RA, Booker, AJ, Vasquez, KM (2006) Targeting oncogenes to improve breast cancer chemotherapy. Cancer Res. 66: 4089–4094 CrossRef
COGEM (2005) Toepassingen van oligonucleotiden. Effecten en potentiële genoomveranderingen (Advies CGM/050707-02). Commissie Genetische Modificatie, The Netherlands. http://www.cogem.net/ (accessed March 3rd, 2009)
COGEM (2006) New techniques in plant biotechnology (COGEM Report CGM/061024-02). Commissie Genetische Modificatie, The Netherlands. http://www.cogem.net/ (accessed March 3rd, 2009)
Cole-Strauss, A, Gamper, H, Holloman, WK, Muñoz, M, Cheng, N, Kmiec, EB (1999) Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res. 27: 1323–1330 CrossRef
Davis BR, Brown DB, Carsrud ND, inventors. February 5, 2004. Single-stranded end-capped oligonucleotide mediated targeted gene repair and modification and uses thereof. United States Patent Application No. 20040023903
De Meyer, SF, Pareyn, I, Baert, J, Deckmyn, H, Vanhoorelbeke K (2007) False positive results in chimeraplasty for von Willebrand Disease. Thromb Res. 119: 93–104 CrossRef
de Semir, D, Aran, JM (2006) Targeted gene repair: the ups and downs of a promising gene therapy approach. Curr. Gene Ther. 6: 481–504 CrossRef
Dong, C, Beetham, P, Vincent, K, Sharp, P (2006) Oligonucleotide-directed gene repair in wheat using a transient plasmid gene repair assay system. Plant Cell Rep. 25: 457–465 CrossRef
EC (1990) Council Directive 90/219/EEC of 23 April 1990, on the contained use of genetically modified micro-organisms. Off. J. Eur. Union L 117: 1–14
EC (1998) Council Directive 98/81/EC of 26 October 1998 amending Directive 90/219/EEC on the contained use of genetically modified micro-organisms. Off. J. Eur. Union L 330: 13–31
EC (2001) Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC. Off. J. Eur. Union L 106: 1–38
EC (2003) Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC. Off. J. Eur. Union L 268: 24–28
Engstrom, JU, Kmiec, EB (2008) DNA replication, cell cycle progression and the targeted gene repair reaction. Cell Cycle 15: 1402–1414 CrossRef
Gamper, HB, Parekh, H, Rice, MC, Bruner, M, Youkey, H, Kmiec, EB (2000) The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucleic Acids Res. 28: 4332–4339 CrossRef
Grabowski, P (2008) Failure to repair the c.338C>T mutation in carnitine palmitoyl transferase 2 deficient skin fibroblasts using chimeraplasty. Mol. Genet. Metabol. 93: 347–349
Hohn, B, Puchta, H (1999) Gene therapy in plants. Proc. Natl. Acad. Sci. 96: 8321–8323 CrossRef
Huen, MS, Li, XT, Lu, LY, Watt, RM, Liu, DP, Huang, JD (2006) The involvement of replication in single stranded oligonucleotide-mediated gene repair. Nucleic Acids Res. 34: 6183–6194 CrossRef
Igoucheva, O, Alexeev, V, Yoon, K (2004a) Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view. Curr. Mol. Med. 4: 445–463 CrossRef
Igoucheva, O, Alexeev, V, Yoon, K (2004b) Mechanism of gene repair open for discussion. Oligonucleotides 14: 311–321 CrossRef
Igoucheva, O, Alexeev, V, Scharer, O, Yoon, K (2006) Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification. Oligonucleotides 16: 94–104 CrossRef
Iida, S, Terada, R (2005) Modification of endogeneous natural genes by gene targeting in rice and other higher plants. Plant Mol. Biol. 59: 205–219 CrossRef
Jacobsen, E, Schouten, HJ (2008) Cisgenesis, a new tool for traditional plant breeding, should be exempted from the regulation on genetically modified organisms in a step by step approach. Potato Res. 51: 75–88 CrossRef
Kalish, JM, Glazer, PM (2005) Targeted genome modification via triple helix formation. Ann. N. Y. Acad. Sci. 1058: 151–161 CrossRef
Kmiec, EB (2003) Targeted gene repair – in the arena. J. Clin. Invest. 112: 632–636 CrossRef
Kochevenko, A, Willmitzer, L (2003) Chimeric RNA/DNA oligonucleotide-based site-specific modification of the tobacco acetolactate syntase gene. Plant Physiol. 132: 174–184 CrossRef
Laible, G, Wagner, S, Alderson, J (2006) Oligonucleotide-mediated gene modification and its promise for animal agriculture. Gene 366: 17–26 CrossRefPubMed
Li, XT, Costantino, N, Lu, LY, Liu, DP, Watt, RM, Cheah, KS, Court, DL, Huang, JD (2003) Identification of factors influencing strand bias in oligonucleotide-mediated recombination in Escherichia coli. Nucleic Acids Res. 31: 6674–6687 CrossRef
Li, J, Hsia, AP, Schnable, PS (2007) Recent advances in plant recombination. Curr. Opin. Plant Biol. 10: 131–135 CrossRef
Liu, L, Rice, MC, Kmiec, EB (2001) In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res. 29: 4238–4250 CrossRef
Liu, L, Rice, MC, Drury, M, Cheng, S, Gamper, H, Kmiec, EB (2002) Strand bias in targeted gene repair is influenced by transcriptional activity. Mol. Cell. Biol. 22: 3852–3863 CrossRef
May GD, Kmiec EB, Rice MC, inventors. November 22, 2001. Plant gene targeting using oligonucleotides. World Intellectual Property Organization No. WO/2001/087914
Murphy, BR, Moayedpardazi, HS, Gewirtz, AM, Diamond, SL, Pierce, EA (2007) Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting. Gene Ther. 14: 304–315 CrossRef
Nielsen, KM (2003) Transgenic organisms – time for conceptual diversification? Nat. Biotechnol. 21: 227–228 CrossRef
Okuzaki, A, Toriyama, K (2004) Chimeric RNA/DNA oligonucleotide-directed gene targeting in rice. Plant Cell Rep. 22: 509–512 CrossRef
Parekh-Olmedo, H, Kmiec, EB (2007) Progress and prospects: targeted gene alteration (TGA). Gene Ther. 14: 1675–1680 CrossRef
Parekh-Olmedo, H, Ferrara, L, Brachman, E, Kmiec, EB (2005) Gene therapy progress and prospects: targeted gene repair. Gene Ther. 12: 639–646 CrossRef
Radecke, S, Radecke, F, Peter, I, Schwarz, K (2006) Physical incorporation of a single-stranded oligodeoxynucleotide during targeted repair of a human chromosomal locus. J. Gene Med. 8: 217–228 CrossRef
Rando TA (2002) Oligonucleotide-mediated gene therapy for muscular dystrophies. Neuromuscul. Disord. Suppl 1: S55–S60
Reiss, B (2003) Homologous recombination and gene targeting in plant cells. Int. Rev. Cytol. 228: 85–139 CrossRef
Ruiter, R, van den Brande, I, Stals, E, Delauré, S, Cornelissen, M, D'Halluin K (2003) Spontaneous mutation frequency in plants obscures the effect of chimeraplasty. Plant Mol. Biol. 53: 675–689
Simon, P, Cannata, F, Concordet, JP, Giovannangeli, C (2008) Targeting DNA with triplex-forming oligonucleotides to modify gene sequence. Biochimie 90: 1109–1116 CrossRef
Sørensen, CB, Krogsdam, AM, Andersen, MS, Kristiansen, K, Bolund, L, Jensen, TG (2005) Site-specific strand bias in gene correction using single-stranded oligonucleotides. J. Mol. Med. 83: 39–49 CrossRef
Storici, F (2008) RNA-mediated DNA modifications and RNA-templated DNA repair. Curr. Opin. Mol. Ther. 10: 224–230
Suzuki, T (2008) Targeted gene modification by oligonucleotides and small DNA fragments in eukaryotes. Front. Biosci. 13: 737–744 CrossRef
Wright, DA, Townsend, JA, Winfrey, RJ Jr, Irwin, PA, Rajagopal, J, Lonosky, PM, Hall, BD, Jondle, MD, Voytas, DF (2005) High-frequency homologous recombination in plants mediated by zinc-finger nucleases. Plant J. 44: 693–705 CrossRef
Wu, XS, Liu, DP, Liang, CC (2001) Prospects of chimeric RNA-DNA oligonucleotides in gene therapy. J. Biomed. Sci. 8: 439–445 CrossRef
Yin, W, Kren, BT, Steer, CJ (2005) Site-specific base changes in the coding or promoter region of the human beta- and gamma-globin genes by single-stranded oligonucleotides. Biochem. J. 390: 253–261 CrossRef
Zhang, Z, Eriksson, M, Falk, G, Graff, C, Presnell, SC, Read, MS, Nichols, TC, Blombäck, M, Anvret, M (1998) Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. Antisense Nucleic Acid Drug Dev. 8: 531–536 CrossRef
Zhu, T, Peterson, DJ, Tagliani, L, St Clair, G, Baszczynski, CL, Bowen, B (1999) Targeted manipulation of maize genes in vivo using chimeric RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. USA 96: 8768–8773 CrossRef
Zhu, T, Mettenburg, K, Peterson, DJ, Tagliani, L, Baszczynski, CL (2000) Engineering herbicide-resistant maize using chimeric RNA/DNA oligonucleotides. Nature Biotech. 18: 555–558